Tilman Schlothauer

Penzberg, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Fusion of IgG antibodies to albumin inhibits transport across the placenta.

Fusion of IgG antibodies to albumin inhibits transport across the placenta.

Journal: Science immunology
Published: August 14, 2026

Development of single-chain C1q affinity chromatography-mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactions.

Development of single-chain C1q affinity chromatography-mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactions.

Journal: mAbs
Published: June 19, 2026

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.

Journal: mAbs
Published: July 08, 2025

Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.

Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.

Journal: mAbs
Published: June 07, 2024

Editorial: New functional separation and analysis technologies utilizing human Fc receptors.

Editorial: New functional separation and analysis technologies utilizing human Fc receptors.

Journal: Frontiers in immunology
Published: May 17, 2024

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end.

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end.

Journal: Communications biology
Published: March 26, 2024

TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization.

TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization.

Journal: Frontiers in immunology
Published: March 15, 2024

Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.

Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling.

Journal: Structure (London, England : 1993)
Published: January 26, 2024

Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcγRIIIa binding.

Benchmarking glycoform-resolved affinity separation - mass spectrometry assays for studying FcγRIIIa binding.

Journal: Frontiers in immunology
Published: December 01, 2023

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.

Journal: mAbs
Published: October 12, 2023

Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes.

Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes.

Journal: Frontiers in immunology
Published: July 17, 2023

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Journal: Nature communications
Published: April 07, 2023
Showing 1-12 of 45

Last Updated: 09/26/2026